Formulation of an ovarian cancer vaccine with the squalene-based AddaVax adjuvant inhibits the growth of murine epithelial ovarian carcinomas.

Autor: Mazumder, Suparna1,2 mazumds@ccf.org, Swank, Valerie1, Dvorina, Nina1, Johnson, Justin M.1, Tuohy, Vincent K.1,2
Zdroj: Clinical & Experimental Vaccine Research. May2022, Vol. 11 Issue 2, p163-172. 10p.
Databáze: Academic Search Ultimate